Ars Pharmaceuticals Inc <SPRY.O>: Leerink Partners cuts target price to $18 from $24
SPRY•Related News
HeartFlow, Inc. <HTFL.O>: JP Morgan Raises Target Price to $45 From $35
HTFL•
Texas Roadhouse director Gregory N. Moore disposes of 3,000 common shares worth $624,960
TXRH•
JPMorgan terminated its banking relationship with Polymarket last year over regulatory concerns
JPM•
Vale releases investor presentation outlining strategy, iron ore and base metals operations
VALE•
Agora forecasts Q3 revenue of $41 million-$42 million, up 15.8%-18.6% yr/yr
API•